ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.080
+0.380 (10.27%)
Aug 27, 2026, 4:08 PM HKT
HKG:1541 Market Cap
HKG:1541 has a market cap or net worth of 1.6 billion as of August 27, 2026. Its market cap has decreased by -68.21% in one year.
Market Cap
1.60B
Enterprise Value
908.41M
Revenue
145.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.08
ChartMarket Cap Chart
Since September 5, 2023, HKG:1541's market cap has decreased from 7.29B to 1.60B, a decrease of -78.09%. That is a compound annual growth rate of -39.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 1.59B | -36.81% |
| Dec 31, 2025 | 2.52B | 19.70% |
| Dec 31, 2024 | 2.10B | -81.21% |
| Dec 29, 2023 | 11.19B | 53.55% |
| Sep 5, 2023 | 7.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AIM Vaccine | 1.97B |
| Guangzhou Innogen Pharmaceutical Group | 1.86B |
| HighTide Therapeutics | 1.84B |
| Mabpharm | 1.77B |
| SinoMab BioScience | 1.54B |
| Zhaoke Ophthalmology | 1.38B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.26B |
| Beijing Biostar Pharmaceuticals | 1.24B |